Abstract Single gene disorders with Mendelian inheritance patterns have contributed greatly to the identification of genes and pathways implicated in genetic disease. In these cases, molecular analysis predicts disease status relatively directly. However, there are many abnormalities which show familial recurrence and have a clear genetic component, but do not show regular Mendelian segregation patterns. Defining the causative gene for non-Mendelian diseases is more difficult, and even when the underlying gene is known, there is uncertainty for prenatal prediction. However, detailed examination of the different mechanisms that underlie non-Mendelian segregation provides insight into the types of interaction that regulate more complex disease genetics. Mendelian inheritance patterns are well-established, and readily recognizable as ‘textbook’ examples, for many single gene diseases (), and a few digenic cases (–). However, in most clinical genetics settings many cases are seen where the disease diagnosed is well known to have a strong genetic component, and show some familial recurrence, but no clear Mendelian inheritance.

Such cases clearly pose additional problems in counselling and the estimation of recurrence risk. Here, we review some of the different molecular mechanisms that lead to such irregular inheritance patterns, focussing mostly on diseases where at least one implicated gene and some underlying mutations have been identified. It is useful to attempt to categorize the different ways in which the observed inheritance patterns are generated (Table ) and then to consider in more detail some examples in each category. Some detailed molecular mechanisms underlying non-Mendelian inheritance patterns will be unfolded below, but first some general concepts need to be clarified. Incomplete penetrance (), where not all mutation carriers present with the expected phenotype, is commonly observed in human family studies. This forms a continuum with variable expressivity, which can be so extreme that subtle manifestations of carrier status are sometimes only identified with hindsight (). Gonki na dvoih pc s dzhojstikom.

Even some of the most classical Mendelian traits, like cystic fibrosis (CF), show complex variation (,). A significant proportion of variability can be ascribed to allelic differences (,), some of which will be cryptic regulatory variation, influencing gene expression levels (,). The existence of widespread variation is not surprising, as gene products fulfil their function through finely tuned interactions with other cellular components, often showing some degree of threshold requirement ().

This page was last edited on 22 February 2019, at 19:53. All structured data from the main, property and lexeme namespaces is available under the Creative Commons CC0.

Each component is subject to regulation, and variation, at every stage: transcription, splicing, translation (), protein folding, oligomerization, translocation and compartmentalization within the cell or export from it (). Subsequently, there is controlled turnover, through well-policed pathways of destruction (,). When focussing on gene products, we mostly think of proteins, but should increasingly remember that many cellular processes are regulated by RNA molecules, or at the RNA level (). The complexity of the proteome is strongly affected by controlled alternative splicing, a mechanism often altered or damaged through sequence variation or mutation. Protein folding, association and sub-cellular localization, also require some helper systems, such as molecular chaperones, which often double as stress response proteins (), and these are very likely implicated in extreme phenotypic variability, and hence segregation pattern variability (,). SPORADIC OCCURRENCE OF GENETICALLY LETHAL SINGLE GENE ANOMALIES An apparently sporadic pattern of disease incidence is observed if virtually all cases arise as a result of new mutation.